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Purpose/Objective: The aim of this study is to validate a 
frameless approach for the integration of two-dimensional 
(2D) digital subtracted angiography (DSA) images with three-
dimensional (3D) computed tomography angiography (CTA) 
and magnetic resonance angiography (MRA) datasets using 
vessel tree segmentation for image registration for 
arteriovenous malformation (AVM) radiosurgery. 
Materials and Methods: A retrospective analysis of 28 AVM 
patients with DSA, CTA and MRA imaging was performed. 
Vessel tree segmentation of CTA/MRA was used to register 
these 3D-image sets with 2D DSA. AVM contouring on DSA is 
projected on the CTA/MRA and used as a guide to segment 
and delineate the lesion on CTA and MRA. Based on these 
contours, the localization accuracy was evaluated comparing 
the new vessel tree-based image registration (frameless 
approach) with external coordinates localization (frame-
based approach).  
Results: In all 28 cases, a vessel tree could be mapped out of 
CTA and MRA datasets and used to register with DSA. DSA 
contouring resulting in a 3D AVM contour on CTA showed a 
mean volume of 1.60 cc for both approaches. The targeting 
accuracy of the new application with vessel tree 
segmentation was found 0.4 ± 0.3 mm, 0.5 ± 0.3 mm and 0.3 
± 0.3 mm for the CC, LAT and AP direction, respectively, 
resulting in an overall 3D vector of 0.8 ± 0.4 mm. The 
agreement ratio, which reflects the similarity between the 
two approaches, was 0.75 ± 0.12. 
Conclusions: Registration of 2D DSA images with 3D CTA/MRA 
based on vessel tree segmentation is a feasible option for 
frameless AVM targeting and showed submillimetric targeting 
accuracy.  
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Purpose/Objective: MLC tracking is a promising method for 
intrafraction tumor motion management by real-time 
adaption of the MLC aperture to the moving target. However, 
limitations in MLC adaptation leads to residual dosimetric 
errors. Here, we present an MLC tracking simulator and 
demonstrate its use for large-scale simulations to quantify 
the dosimetric benefit of potential tracking system design 
improvements 
Materials and Methods: A Varian TrueBeam accelerator with 
MLC tracking guided by the Calypso electromagnetic 
transponder system was used as reference for the simulator. 
The Calypso system delivers a 3D position of the target every 
40ms to the tracking system. Similar to the accelerator, the 
tracking simulator performs three steps every 10ms. 1) 
Estimate the target position, 2) fit the MLC shape to the 
estimated target position, and 3) adjust the MLC leaves to 
the fitted MLC shape. For each of these three steps, the 
residual adaptation error was quantified by the under-
exposed area Au (MLC shielded area that should ideally be 
exposed) and the over-exposed area Ao (MLC exposed area 
that should ideally be shielded). It has previously been shown 
that Au+Ao is a good surrogate for the dosimetric error. 
Tracking log files from the accelerator were analyzed and 
used to build the MLC dynamics into the simulator. 
The MLC tracking simulator was used to test the following 
potential improvements of the tracking system: A) Halving 
the latency (improves target localization), B) Halving the MLC 
leaf width from 5 mm to 2.5 mm (improves MLC fitting), C) 
Dynamic alignment of the collimator during arc treatments 
such that the leaves move along a preferred target motion 
direction (improves MLC fitting). For all potential 
improvements, the reduction in Au+Ao was calculated and 
used to test whether the improvement was statistically 
significant. The base system and each simulated improved 
system were tested with two high-modulated VMAT plans 
(lung and prostate) for 100 patient-measured tumor traces 
from motion databases (50 lung and 50 prostate). Only traces 
with motion larger than 5 mm were chosen for the 
simulations. 
Results: For lung, the mean Au+Ao was on average reduced 
by 5.4 % (Half latency, p= 0.00), 23.5 % (Half leaf width, p= 
0.00) and 10.8 % (Dynamic collimator rotation, p= 0.04) by 
the tested tracking system improvements. For prostate, 
Au+Ao was reduced by 6.36 % (Half latency, p= 0.00), 21.1% 
(Half leaf with, p= 0.00) and 8 % (Dynamic collimator 
rotation, p= 0.10). The figure illustrates that for both tumor 
sites, the primary source of residual errors is leaf fitting, 
followed by leaf adjustment errors for lung tumor motion and 
by errors caused by the latency for prostate motion. 
 
Conclusions: A framework for MLC tracking simulations was 
built. All system modification simulated gave a reduction of 
the residual error, however it was not statistical significant 
for prostate and collimator rotation. For both prostate and 
lung tumor motion, halved leaf width resulted in the largest 
tracking performance improvement.  
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Purpose/Objective: The clinical use of EBRT and BT dose 
accumulation for cervical cancer is hampered by the 
unknown dosimetric impact of unavoidable geometrical 
uncertainties originating from the non-rigid mapping of intra-
patient anatomies. In a recent study, these geometrical 
uncertainties were quantified for a novel non-rigid 
